Trading Signals: IBIO Stock Price Prediction and Forecast (Tue. Aug. 19, 2008 - Fri. Jul. 24, 2020)(iBio Inc. (ASE))
| IBIO latest price $22.5000 (1.81%) ($22.0000 - $23.8000) on Mon. Oct. 11, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 40 | Latest Price | $22.5000(1.81%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | IBIO declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IBIO advance at 0% a week (0% probability) PEJ(5%) IWM(4%) IGOV(3%) OIH(3%) QQQ(3%) | Factors Impacting IBIO price | IBIO will decline at least -1.19% in a week (0% probabilities). PCY(-3%) XLU(-2%) FXI(-2%) EEM(-2%) VWO(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
Resistance Level | $22.93 | 5 Day Moving Average | $22.16(1.53%) | 10 Day Moving Average | $22.49(0.04%) | 20 Day Moving Average | $22.93(-1.88%) | To recent high | -5.1% | To recent low | 63% | Market Cap | $2.416b | | | | iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY. |